These data encourage the use of such a combination treatment as a

These data encourage the use of such a combination treatment as a therapeutic strategy against KSHV associated malignancies. Acknowledgements We thank Sandro Valia for photographic Bucladesine mw work. We thank Marina Peddis, Giulia Di Giovenale and Valentina Lacconi for technical help. Funding This work was supported by

grants from MIUR, Associazione Italiana per la ricerca sul Cancro (AIRC) (Grant n. 10265), and Pasteur Cenci-Bolognetti foundation. References 1. Boshoff C, Weiss R: AIDS-related malignancies. Nat Rev Cancer 2002, 2:373–382.GM6001 price PubMedCrossRef 2. Chakraborty S, Veettil MV, Chandran B: Kaposi’s Sarcoma associated herpesvirus entry into target cells. Front Microbiol 2012, 3:6.PubMed 3. Jeffery HC, Wheat RL, Blackbourn DJ, Nash GB, Butler LM: Infection and transmission dynamics of rKSHV.219 In primary endothelial cells. J Virol Methods 2013, 193:251–259.PubMedCrossRef 4. Chandran B: Early events selleck chemicals in Kaposi’s sarcoma-associated herpesvirus infection

of target cells. J Virol 2010, 84:2188–2199.PubMedCrossRef 5. Hassman LM, Ellison TJ, Kedes DH: KSHV infects a subset of human tonsillar B cells, driving proliferation and plasmablast differentiation. J Clin Invest 2011, 121:752–768.PubMedCrossRef 6. Cirone M, Lucania G, Bergamo P, Trivedi P, Frati L, Faggioni A: Human herpesvirus 8 (HHV-8) inhibits monocyte differentiation into dendritic cells and impairs their immunostimulatory activity. Immunol Lett 2007, 113:40–46.PubMedCrossRef 7. Birkmann A, Mahr K, Ensser A, Yaguboglu S, Titgemeyer F, Fleckenstein B, Neipel F: Cell surface heparan sulfate is a receptor for human herpesvirus 8 and interacts with envelope glycoprotein K8.1. J Virol 2001, 75:11583–11593.PubMedCrossRef 8. Kerur N, Veettil MV, Sharma-Walia N, Sadagopan S, Bottero V, Paul AG, Chandran B: Characterization of entry and infection of monocytic THP-1 cells by Kaposi’s sarcoma associated herpesvirus (KSHV): role of heparan

sulfate, DC-SIGN, integrins and signaling. Virol 2010, 406:103–116.CrossRef 9. Rappocciolo G, Jenkins FJ, Hensler HR, Piazza P, Jais M, Borowski L, Sclareol Watkins SC, Rinaldo CR Jr: DC-SIGN is a receptor for human herpesvirus 8 on dendritic cells and macrophages. J Immunol 2006, 176:1741–1749.PubMed 10. Rappocciolo G, Hensler HR, Jais M, Reinhart TA, Pegu A, Jenkins FJ, Rinaldo CR: Human herpesvirus 8 infects and replicates in primary cultures of activated B lymphocytes through DC-SIGN. J Virol 2008, 82:4793–4806.PubMedCrossRef 11. Tsuchiya S, Yamabe M, Yamaguchi Y, Kobayashi Y, Konno T, Tada K: Establishment and characterization of a human acute monocytic leukemia cell line (THP-1). Int J Cancer 1980, 26:171–176.PubMedCrossRef 12.

Comments are closed.